aHUS Observational Long Term Follow-Up

Study Identifier:
C11-003
ClinicalTrials.gov Identifier:
NCT01522170
EudraCT Identifier:
N/A
Sponsor:
Alexion Pharmaceuticals, Inc.
Study Contact Information:
N/A
Other

Study Details

Medical Condition
  • Unmapped
Study Drug
    Date
    Mar 2012 - Jan 2017
    Phase 1
    Phase 2
    Phase 3
    Phase 4
    N/A
    Patient Requirements
    Sex: Female & Male
    Age: N/A - N/A
    Requirements Information
    Sex
    Female & Male
    Age
    N/A - N/A

    Study Details

    Medical Condition
    • Unmapped
    Study Drug
      Date
      Mar 2012 - Jan 2017
      Phase 1
      Phase 2
      Phase 3
      Phase 4
      N/A
      Patient Requirements
      Sex: Female & Male
      Age: N/A - N/A years
      Requirements Information

      Protocol Summary

      There is growing but limited information on the long term clinical status of aHUS patients who have previously received or are continuing to receive treatment with eculizumab. This study is designed to collect clinical data that will provide insight into the long-term outcomes of patients with aHUS.

      Trial Locations

      Location
      Status
      Location
      Emory Healthcare - Children's Center
      Atlanta, Georgia, United States
      Status
      N/A
      Location
      Dunwoody Pediatrics & Children's Healthcare of Atlanta
      Dunwoody, Georgia, United States
      Status
      N/A
      Location
      Fort Wayne Medical Oncology and Hematology
      Fort Wayne, Indiana, United States
      Status
      N/A
      Location
      Fort Wayne, Indiana, United States
      Status
      N/A
      Location
      Boston Children's Hospital
      Boston, Massachusetts, United States
      Status
      N/A
      Location
      Henry Ford Health System
      Detroit, Michigan, United States
      Status
      N/A